tirzepatide weight loss clinical results Diabetes Distilled: “Twincretin” significantly SURPASSes comparator effects on glucose, and quality of life Tirzepatide weight-loss study shows promising

Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: The SURPASS-5 randomized clinical trial

While the exact cause of PD remains unknown, research has identified several genetic factors and environmental influences that may contribute to its development

The degree of deterioration depends on baseline diabetes severity, duration of disease, beta-cell function, and effectiveness of replacement therapies

The slow, supervised dose titration protocol we follow at BlueWater Wellness Center is specifically designed to minimize side effect burden during this adjustment period

This represents an atypical response rather than the medication's intended effect

Insulin Syringes (U-100) Use 0.3 mL / 30-unit syringes for small draws (low-dose reta, low-dose MOTS-c)